Charles Anthony Laranjeira - Nov 22, 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Technical Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Nov 22, 2021
Transactions value $
$330,750
Form type
4
Date filed
11/24/2021, 03:25 PM
Previous filing
Jun 11, 2021
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Options Exercise $331K +7.5K +28.73% $44.10 33.6K Nov 22, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -7.5K -100% $0.00* 0 Nov 22, 2021 Common Stock 7.5K $44.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.
F2 The stock option vested and became exercisable as to 25% of the option shares on May 1, 2018, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date.